Resistance of a vaccinia virus A34R deletion mutant to spontaneous rupture of the outer membrane of progeny virions on the surface of infected cells

Virology

Volumn 366, Issue 2, 2007, Pages 424-432

  Husain, Matloob ^a   Weisberg, Andrea S ^a   Moss, Bernard ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Poxvirus virions; Vaccinia virus mutants; Viral membrane

Indexed keywords

GLYCOSAMINOGLYCAN;

ANIMAL EXPERIMENT; ARTICLE; CELL LINE; CELL SURFACE; CONTROLLED STUDY; DELETION MUTANT; FLUORESCENCE MICROSCOPY; MOUSE; NONHUMAN; OUTER MEMBRANE; PLAQUE FORMING CELL; PRIORITY JOURNAL; PROGENY; RAT; TRANSMISSION ELECTRON MICROSCOPY; VIRUS INFECTIVITY; VIRUS RESISTANCE;

ANIMALS; CELL LINE; GENE DELETION; GLYCOPROTEINS; HUMANS; MICROSCOPY, FLUORESCENCE; MICROSCOPY, IMMUNOELECTRON; VACCINIA VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL MATRIX PROTEINS; VIRION; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

POXVIRIDAE; VACCINIA VIRUS;

EID: 34548570106     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.05.015     Document Type: Article

References (36)

1. Banfield B.W., Leduc Y., Esford L., Schubert K., and Tufaro F. Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: evidence for a proteoglycan-independent virus entry pathway. J. Virol. 69 (1995) 3290-3298
2. Blasco R., and Moss B. Role of cell-associated enveloped vaccinia virus in cell-to-cell spread. J. Virol. 66 (1992) 4170-4179
3. Blasco R., Sisler J.R., and Moss B. Dissociation of progeny vaccinia virus from the cell membrane is regulated by a viral envelope glycoprotein: effect of a point mutation in the lectin homology domain of the A34R gene. J. Virol. 67 (1993) 3319-3325
4. Carter G.C., Law M., Hollinshead M., and Smith G.L. Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. J. Gen. Virol. 86 (2005) 1279-1290
5. Condit R.C., Moussatche N., and Traktman P. In a nutshell: structure and assembly of the vaccinia virion. Adv. Virus Res. 66 (2006) 31-124
6. da Fonseca F.G., Wolffe E.J., Weisberg A., and Moss B. Effects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication. J. Virol. 74 (2000) 7518-7528
7. Earl P.L., Cooper N., Wyatt S., Moss B., and Carroll M.W. Preparation of cell cultures and vaccinia virus stocks. In: Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., and Struhl K. (Eds). Current Protocols in Molecular Biology vol. 2 (1998), John Wiley and Sons, New York 16.16.1-16.16.3
8. Husain M., Weisberg A., and Moss B. Topology of epitope-tagged F13L protein, a major membrane component of extracellular vaccinia virions. Virology 308 (2003) 233-242
9. Ichihashi Y. Extracellular enveloped vaccinia virus escapes neutralization. Virology 217 (1996) 478-485
10. Izmailyan R.A., Huang C.Y., Mohammad S., Isaacs S.N., and Chang W. The envelope G3L protein is essential for entry of vaccinia virus into host cells. J. Virol. 80 (2006) 8402-8410
11. Law M., Carter G.C., Roberts K.L., Hollinshead M., and Smith G.L. Ligand-induced and non-fusogenic dissolution of a viral membrane. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 5989-5994
12. McIntosh A.A., and Smith G.L. Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J. Virol. 70 (1996) 272-281
13. Moss B. Poxvirus entry and membrane fusion. Virology 344 (2006) 48-54
14. Moss B. Poxviridae: the viruses and their replicaton. In: Knipe D.M. (Ed). Fields Virology vol. 2 (2007), Lippincott Williams and Wilkins, Philadelphia 2905-2946
15. Moss B., and Ward B.M. High-speed mass transit for poxviruses on microtubules. Nat. Cell Biol. 3 (2001) E245-E246
16. Ojeda S., Domi A., and Moss B. Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex. J. Virol. 80 (2006) 9822-9830
17. Ojeda S., Senkevich T.G., and Moss B. Entry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene. J. Virol. 80 (2006) 51-61
18. Payne L.G. Significance of extracellular virus in the in vitro and in vivo dissemination of vaccinia virus. J. Gen. Virol. 50 (1980) 89-100
19. Roos N., Cyrklaff M., Cudmore S., Blasco R., Krijnse-Locker J., and Griffiths G. A novel immunogold cryoelectron microscopic approach to investigate the structure of the intracellular and extracellular forms of vaccinia virus. EMBO J. 15 (1996) 2343-2355
20. Roper R., Wolffe E.J., Weisberg A., and Moss B. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus. J. Virol. 72 (1998) 4192-4204
21. Sanderson C.M., Frischknecht F., Way M., Hollinshead M., and Smith G.L. Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion. J. Gen. Virol. 79 (1998) 1415-1425
22. Senkevich T.G., and Moss B. Vaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusion. J. Virol. 79 (2005) 4744-4754
23. Senkevich T.G., Ward B.M., and Moss B. Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene. J. Virol. 78 (2004) 2357-2366
24. Senkevich T.G., Ojeda S., Townsley A., Nelson G.E., and Moss B. Poxvirus multiprotein entry-fusion complex. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 18572-18577
25. Smith G.L., Vanderplasschen A., and Law M. The formation and function of extracellular enveloped vaccinia virus. J. Gen. Virol. 83 (2002) 2915-2931
26. Townsley A., Senkevich T.G., and Moss B. The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion. J. Virol. 79 (2005) 10988-10998
27. Townsley A., Senkevich T.G., and Moss B. Vaccinia virus A21 virion membrane protein is required for cell entry and fusion. J. Virol. 79 (2005) 9458-9469
28. Turner P.C., and Moyer R.W. The cowpox virus fusion regulator proteins SPI-3 and hemagglutinin interact in infected and uninfected cells. Virology 347 (2006) 88-99
29. Vanderplasschen A., and Smith G.L. A novel virus binding assay using confocal microscopy: demonstration that intracellular and extracellular vaccinia virions bind to different cellular receptors. J. Virol. 71 (1997) 4032-4041
30. Vanderplasschen A., Hollinshead M., and Smith G.L. Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and spread. Gen. Virol. 78 (1997) 2041-2048
31. Vanderplasschen A., Hollinshead M., and Smith G.L. Intracellular and extracellular vaccinia virions enter cells by different mechanisms. J. Gen. Virol. 79 (1998) 877-887
32. Wagenaar, T.R., Moss, B., in press. Association of vaccinia virus fusion regulatory proteins with the multicomponent entry/fusion complex. J. Virol.
33. Ward B.M., Weisberg A.S., and Moss B. Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteins. J. Virol. 77 (2003) 4113-4126
34. Wolffe E.J., Isaacs S.N., and Moss B. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J. Virol. 67 (1993) 4732-4741
35. Wolffe E.J., Katz E., Weisberg A., and Moss B. The A34R glycoprotein gene is required for induction of specialized actin-containing microvilli and efficient cell-to-cell transmission of vaccinia virus. J. Virol. 71 (1997) 3904-3915
36. Wolffe E.J., Weisberg A.S., and Moss B. Role for the vaccinia virus A36R outer envelope protein in the formation of virus-tipped actin-containing microvilli and cell-to-cell virus spread. Virology 244 (1998) 20-26